NHC director granted options on 7,500 shares
National Healthcare Corp director William A. Adams received a grant of options on 7,500 shares of common stock.
Rhea-AI Filing Summary
National Healthcare Corp director William A. Adams received a grant of options on 7,500 shares of common stock. The options were granted on May 7, 2026 under the company’s 2020 Omnibus Equity Incentive Plan with a stated exercise price of $0.00 per share and expire on May 6, 2030. Following this award, Adams holds options covering 7,500 shares directly as reported in this filing. The grant and potential exercise are described as exempt from Section 16(b) under Rule 16b-3(d), indicating this is a routine equity-based compensation award for a board member.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 7,500 shares
Grant/Award
1 txn
Insider
Adams William A.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option to Purchase Common Stock [2026 Grant] | 7,500 | $0.00 | $0.00 |
Holdings After Transaction:
Option to Purchase Common Stock [2026 Grant] — 7,500 contracts (Direct)
Footnotes (1)
- F1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Key Figures
Options granted: 7,500 shares
Exercise price: $0.00 per share
Total options held after grant: 7,500 shares
+2 more
5 metrics
Options granted
7,500 shares
Options to purchase common stock granted May 7, 2026
Exercise price
$0.00 per share
Stated option exercise price for the 7,500-share grant
Total options held after grant
7,500 shares
Total option shares following the reported transaction
Grant date
May 7, 2026
Date options to purchase common stock were awarded
Expiration date
May 6, 2030
Scheduled expiration of the granted stock options
Key Terms
2020 Omnibus Equity Incentive Plan, Section 16(b), Rule 16b-3(d), stock options
4 terms
2020 Omnibus Equity Incentive Plan financial
"These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026."
Section 16(b) regulatory
"The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d)."
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
Rule 16b-3(d) regulatory
"The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d)."
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
stock options financial
"These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NHC director William A. Adams report?
William A. Adams reported receiving a grant of stock options for 7,500 shares of National Healthcare Corp common stock. The award is a routine compensation grant made on May 7, 2026 under the company’s 2020 Omnibus Equity Incentive Plan.
What are the key terms of William A. Adams’ NHC stock option grant?
The grant covers options on 7,500 shares of National Healthcare Corp common stock with a stated exercise price of $0.00 per share. The options were granted May 7, 2026 and are scheduled to expire on May 6, 2030, providing a multi-year equity incentive.
Is William A. Adams’ NHC stock option grant considered a purchase or a compensation award?
The filing characterizes the transaction as a grant or award acquisition, not an open-market purchase. It is a derivative grant of options issued at $0.00 per share under the 2020 Omnibus Equity Incentive Plan, representing standard equity-based director compensation.
How many NHC options does William A. Adams hold after this reported grant?
After the reported transaction, William A. Adams holds options on 7,500 shares of National Healthcare Corp common stock directly. The total shares following the transaction shown in the filing match the 7,500 options granted in this award.
Under what plan were William A. Adams’ NHC stock options granted?
The options were granted pursuant to National Healthcare Corp’s 2020 Omnibus Equity Incentive Plan. This plan provides for equity-based awards to eligible participants, and the filing notes the grant is exempt from Section 16(b) under Rule 16b-3(d).
AI-generated analysis. How Rhea-AI works. Not financial advice.
